BlackRock Health Sciences Trust II
BMEZ
88 hedge funds and large institutions have $215M invested in BlackRock Health Sciences Trust II in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 12 closing their positions.
111% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 18
33% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 12
2% more funds holding
Funds holding: 86 → 88 (+2)
1.24% more ownership
Funds ownership: 12.85% → 14.08% (+1.2%)
4% more capital invested
Capital invested by funds: $206M → $215M (+$8.68M)
Top Buyers
| 1 |
SCM
Saba Capital Management
New York
|
+$11.3M |
| 2 |
1CP
1607 Capital Partners
Richmond,
Virginia
|
+$7.64M |
| 3 |
AC
Almitas Capital
Santa Monica,
California
|
+$5.25M |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$4.54M |
| 5 |
Lazard Asset Management
New York
|
+$3.61M |
Top Sellers
BMEZ Hedge Fund Activity: Q1 2026 in Review
88 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in BlackRock Health Sciences Trust II (BMEZ) for Q1 2026, worth a combined $215M — up 4.2% from $206M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new BMEZ positions and 12 closed out — a net gain of 4 holders — while 38 added to existing stakes and 18 trimmed.
The largest buyer was Saba Capital Management, opening a new position worth an estimated $11.3M. The largest seller was Penserra Capital Management, cutting an estimated $14.4M.
- 88 institutional investors held BlackRock Health Sciences Trust II (BMEZ) as of Q1 2026, up from 86 in Q4 2025.
- Funds reported $215M of BlackRock Health Sciences Trust II stock for Q1 2026, up 4.2% quarter-over-quarter.
- 16 funds opened new BlackRock Health Sciences Trust II positions in Q1 2026 and 12 closed out, a net change of +4 holders.
- The largest BlackRock Health Sciences Trust II buyer in Q1 2026 was Saba Capital Management, an estimated $11.3M added.
- The largest BlackRock Health Sciences Trust II seller in Q1 2026 was Penserra Capital Management, an estimated $14.4M sold.
Based on aggregated 13F filings for Q1 2026.